[HTML][HTML] Deregulation of HLA-I in cancer and its central importance for immunotherapy
It is now well accepted that many tumors undergo a process of clonal selection which means
that tumor antigens arising at various stages of tumor progression are likely to be …
that tumor antigens arising at various stages of tumor progression are likely to be …
Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma
P Chai, R Jia, Y Li, C Zhou, X Gu, L Yang, H Shi… - Progress in retinal and …, 2022 - Elsevier
Uveal melanoma (UM) and retinoblastoma (RB), which cause blindness and even death,
are the most frequently observed primary intraocular malignancies in adults and children …
are the most frequently observed primary intraocular malignancies in adults and children …
Uveal melanoma: Progress in molecular biology and therapeutics
Uveal melanoma (UM) is the most common intraocular malignancy in adults. So far, no
systemic therapy or standard treatment exists to reduce the risk of metastasis and improve …
systemic therapy or standard treatment exists to reduce the risk of metastasis and improve …
[HTML][HTML] Genetic landscape and emerging therapies in uveal melanoma
RS Seedor, M Orloff, T Sato - Cancers, 2021 - mdpi.com
Simple Summary Uveal melanoma is the most common primary intraocular malignancy in
adults. Unfortunately, metastasis develops in up to 50% of cases and outcomes are poor for …
adults. Unfortunately, metastasis develops in up to 50% of cases and outcomes are poor for …
[HTML][HTML] How to make immunotherapy an effective therapeutic choice for uveal melanoma
Simple Summary Despite improvements in the early identification and successful control of
primary uveal melanoma, 50% of patients will develop metastatic disease with only marginal …
primary uveal melanoma, 50% of patients will develop metastatic disease with only marginal …
Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors
Solid tumors including skin, lung, breast, colon, and prostate cancers comprise the most
diagnosed cancers worldwide. Treatment of such cancers is still challenging specially in the …
diagnosed cancers worldwide. Treatment of such cancers is still challenging specially in the …
Clinical trials in metastatic uveal melanoma: Immunotherapy
M Orloff - Ocular Oncology and Pathology, 2021 - karger.com
Background: Uveal melanoma (UM) is a rare subtype of melanoma that generally has a poor
prognosis once it has metastasized. Clinical trials evaluating immune checkpoint inhibitors …
prognosis once it has metastasized. Clinical trials evaluating immune checkpoint inhibitors …
Novel approaches to the systemic management of uveal melanoma
S Khan, RD Carvajal - Current Oncology Reports, 2020 - Springer
Abstract Purpose of Review Uveal melanoma is a distinct subtype of melanoma
characterized by a unique biology and divergent response to immune therapies. In this …
characterized by a unique biology and divergent response to immune therapies. In this …
[HTML][HTML] Targeted Therapy in Ophthalmic Oncology: The Current Status
M Sen, H Demirci, SG Honavar - Asia-Pacific Journal of Ophthalmology, 2024 - Elsevier
There have been rapid advancements in the field of ocular oncology for the diagnosis and
management of intraocular, adnexal, and orbital tumors. Targeted therapy is in the forefront …
management of intraocular, adnexal, and orbital tumors. Targeted therapy is in the forefront …
[HTML][HTML] Thinking small: Small molecules as potential synergistic adjuncts to checkpoint inhibition in melanoma
AC Chacon, AD Melucci, SS Qin, PA Prieto - International Journal of …, 2021 - mdpi.com
Metastatic melanoma remains the deadliest form of skin cancer. Immune checkpoint
inhibition (ICI) immunotherapy has defined a new age in melanoma treatment, but …
inhibition (ICI) immunotherapy has defined a new age in melanoma treatment, but …